The prospects and challenges of universal vaccines for influenza
about
Immunologic consequences of chemotherapy for ovarian cancer: impaired responses to the influenza vaccineMVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 virusesImproving pandemic H5N1 influenza vaccines by combining different vaccine platforms.Single-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells.Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection.Options and obstacles for designing a universal influenza vaccineChallenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories.Influenza vaccines: challenges and solutions.Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in MiceMicroneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins.Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology.Hemagglutinin Stalk Immunity Reduces Influenza Virus Replication and Transmission in Ferrets.Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection.Expression of surface-bound nonstructural 1 (NS1) protein of influenza virus A H5N1 on Lactobacillus casei strain C1.High-Yield Expression of M2e Peptide of Avian Influenza Virus H5N1 in Transgenic Duckweed Plants.Immunogenicity and efficacy of replication-competent recombinant influenza virus carrying multimeric M2 extracellular domains in a chimeric hemagglutinin conjugate.Computationally-driven identification of antibody epitopes.A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.Eliciting unnatural immune responses by activating cryptic epitopes in viral antigens.
P2860
Q30353632-177E4A3F-6444-482A-9F05-7E1CC9E9E8FDQ30358935-B39F2B31-5CA6-4B50-A5C5-3200A4BF7404Q30362811-730D3A89-8657-48CA-A888-1D9347DD937CQ30376518-5B855913-0E4A-4119-A0AF-68ED200C2FF3Q30385423-DCD62E94-FF5A-48CA-BE9A-62762C1429F6Q34102290-887AC575-37BD-41FD-B557-7E1486A0F934Q34332806-FE5FCD55-F0E5-448B-BA22-4D915082E856Q35184572-25DD7E8F-F613-408D-A9F7-F9AAEAE75A57Q35667123-E9630C1B-8CBA-4E58-B160-25569D12840CQ35811003-EFCAEBCE-C028-4D76-8C03-6CA56A695E51Q37395095-46F825B3-3DD3-45AE-BBCB-DE61170EF48DQ38554795-BD4F8C22-B8FB-47B0-82E3-3BF264991C3AQ39602267-021E9D69-2890-4797-8E1A-8AF89F8C5918Q40050261-BBF06F4B-AB7D-4350-97EC-43404D371DB4Q40261399-1145FED9-EA55-4045-B90E-F6A5D02E9994Q42157410-C06BB539-F64A-40B1-914F-45FB8F832FDEQ45325239-01BFBDE9-E9FE-4260-916F-E90EC294BE0AQ47098066-CD0F50D5-B8C4-471E-863F-C64C15067276Q47608146-2A43B50B-275F-4AD0-B2A6-DE7A2B4D0D83Q52344693-D7E8483E-044C-48C0-AD52-F2F279EA57A1
P2860
The prospects and challenges of universal vaccines for influenza
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The prospects and challenges of universal vaccines for influenza
@ast
The prospects and challenges of universal vaccines for influenza
@en
type
label
The prospects and challenges of universal vaccines for influenza
@ast
The prospects and challenges of universal vaccines for influenza
@en
prefLabel
The prospects and challenges of universal vaccines for influenza
@ast
The prospects and challenges of universal vaccines for influenza
@en
P2860
P1476
The prospects and challenges of universal vaccines for influenza
@en
P2093
Yumiko Matsuoka
P2860
P304
P356
10.1016/J.TIM.2013.04.003
P577
2013-05-17T00:00:00Z